Purple Biotech Ltd.
Stock Forecast, Prediction & Price Target
Purple Biotech Ltd. Financial Estimates
Purple Biotech Ltd. Revenue Estimates
Purple Biotech Ltd. EBITDA Estimates
Purple Biotech Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $-320K N/A | $-910K -184.37% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $7.7M Low: $7.7M High: $7.7M avg. 0% | Avg: $36.4M Low: $36.4M High: $36.4M avg. 372.72% | Avg: $60.6M Low: $60.6M High: $60.6M avg. 66.48% |
Net Income
% change YoY
| $-18.46M N/A | $-20.82M -12.79% | $-19.88M 4.53% | Avg: $-17M Low: $-11.69M High: $-11.69M avg. 14.48% | Avg: $-10.58M Low: $-10.58M High: $-10.58M avg. 37.72% | Avg: $-6.15M Low: $-6.15M High: $-6.15M avg. 41.86% | Avg: $-3.93M Low: $-3.93M High: $-3.93M avg. 36.00% |
EBITDA
% change YoY
| $-17.38M N/A | $-21.43M -23.29% | $-22.22M -3.69% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $1.53M Low: $1.53M High: $1.53M avg. 0% | Avg: $7.27M Low: $7.27M High: $7.27M avg. 372.72% | Avg: $12.11M Low: $12.11M High: $12.11M avg. 66.48% |
EPS
% change YoY
| -$1.04 N/A | -$1.13 -8.65% | -$0.09 92.05% | Avg: -$0.48 Low: -$0.48 High: -$0.48 avg. -428.95% | Avg: -$0.43 Low: -$0.43 High: -$0.43 avg. 9.47% | Avg: -$0.25 Low: -$0.25 High: -$0.25 avg. 41.86% | Avg: -$0.16 Low: -$0.16 High: -$0.16 avg. 36% |
Operating Expenses
% change YoY
| $17.93M N/A | $22.60M 26.03% | $-22.46M -199.39% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $-19.41M Low: $-19.41M High: $-19.41M avg. 0% | Avg: $-91.76M Low: $-91.76M High: $-91.76M avg. -372.72% | Avg: $-152.76M Low: $-152.76M High: $-152.76M avg. -66.48% |
FAQ
What is Purple Biotech Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 32.51% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -11.69M, average is -17M and high is -11.69M.
What is Purple Biotech Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 109.80% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Purple Biotech Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -85.40% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.48, average is -$0.48 and high is $-0.47.
What is the best performing analyst?
In the last twelve months analysts have been covering Purple Biotech Ltd. stock. The most successful analyst is Matthew Barcus.